Published in Haematol Blood Transfus on January 01, 1990
International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood (1997) 20.41
A neural cocktail-party processor. Biol Cybern (1986) 2.45
Cardiopulmonary auscultation: duo for strings--Opus 99. Arch Intern Med (1999) 2.26
[Focal nodular hyperplasia of the liver]. Dtsch Med Wochenschr (1992) 2.01
Spiral K-space MR imaging of cortical activation. J Magn Reson Imaging (1995) 1.98
Clinical, morphological, cytogenetic, and prognostic features of patients with myelodysplastic syndromes and del(5q) including band q31. Leukemia (2004) 1.90
Pathologic rupture of the spleen in hematologic malignancies: two additional cases. Ann Hematol (1996) 1.66
Attentional control of visual perception: cortical and subcortical mechanisms. Cold Spring Harb Symp Quant Biol (1990) 1.61
Problems in the classification of CMML--dysplastic versus proliferative type. Leuk Res (1998) 1.60
Blunted erythropoietin production and decreased erythropoiesis in early pregnancy. Blood (1991) 1.52
The use and impact of rapid health technology assessments. Int J Technol Assess Health Care (2000) 1.51
Impact of adjunct cytogenetic abnormalities for prognostic stratification in patients with myelodysplastic syndrome and deletion 5q. Leukemia (2010) 1.48
Age-related incidence and other epidemiological aspects of myelodysplastic syndromes. Br J Haematol (1992) 1.47
Prognostic significance of bcl-2 protein expression in aggressive non-Hodgkin's lymphoma. Groupe d'Etude des Lymphomes de l'Adulte (GELA). Blood (1996) 1.47
Two types of acquired idiopathic sideroblastic anaemia (AISA) Br J Haematol (1990) 1.45
Primary myelodysplastic syndromes: analysis of prognostic factors in 235 patients and proposals for an improved scoring system. Leukemia (1992) 1.45
Pericardial effusion in chronic myelomonocytic leukemia (CMML): a case report and review of the literature. Leuk Res (2000) 1.42
Effective treatment of Jo-1-associated polymyositis with T-cell-depleted autologous peripheral blood stem cell transplantation. Br J Haematol (2000) 1.41
Persistent tumor 18F-FDG uptake after a few cycles of polychemotherapy is predictive of treatment failure in non-Hodgkin's lymphoma. Haematologica (2000) 1.41
[Replantation at lower leg level]. Chirurg (2003) 1.40
[The superior vena cava syndrome as an oncological emergency]. Dtsch Med Wochenschr (1992) 1.40
Direct measurement by pH-microelectrode of the pH microclimate in rat proximal jejunum. Proc R Soc Lond B Biol Sci (1975) 1.40
[Cholesterol--a marker for multiple risk factors? A comparison between coronary disease and coronary health]. Dtsch Med Wochenschr (1992) 1.39
[On the effect of the depot gestagen, 17alpha-hydroxy-19-norprogesterone capronate (SH 582)]. Geburtshilfe Frauenheilkd (1968) 1.39
Combined suicide and cytokine gene therapy for peritoneal carcinomatosis. Gut (2000) 1.39
Increases of sICAM-1 during neutropenic pneumonia in leukemic patients. Leukemia (1997) 1.39
Neutrophilic eccrine hidradenitis. A case report. Acta Clin Belg (1993) 1.38
Renal anaemia of an unusual origin. Nephrol Dial Transplant (2001) 1.38
Storage iron kinetics. VII. A biologic model for reticuloendothelial iron transport. J Clin Invest (1974) 1.38
[Results of a comparative study on enzyme-containing and enzyme-free detergents]. Berufsdermatosen (1972) 1.33
Five-year-survey of invasive aspergillosis in a paediatric cancer centre. Epidemiology, management and long-term survival. Mycoses (1999) 1.33
Hypertension-induced end-organ damage : A new transgenic approach to an old problem. Hypertension (1999) 1.32
A prospective, randomised, phase II study of horse antithymocyte globulin vs rabbit antithymocyte globulin as immune-modulating therapy in patients with low-risk myelodysplastic syndromes. Leukemia (2004) 1.28
Incidence and clinical risk factors for bleeding and thrombotic complications in myeloproliferative disorders. A retrospective analysis of 260 patients. Ann Hematol (1991) 1.28
Survival, prognostic factors and rates of leukemic transformation in 381 untreated patients with MDS and del(5q): a multicenter study. Leukemia (2012) 1.27
Distinguishing myelodysplastic syndromes (MDS) from idiopathic cytopenia of undetermined significance (ICUS): HUMARA unravels clonality in a subgroup of patients. Ann Oncol (2010) 1.26
Improved outcome in adult B-cell acute lymphoblastic leukemia. Blood (1996) 1.26
Cellular uptake of saposin (SAP) precursor and lysosomal delivery by the low density lipoprotein receptor-related protein (LRP). EMBO J (1998) 1.25
Inhibition of transformation of normal lymphocytes by plasma factor from patients with Hodgkin's disease and cancer. Lancet (1971) 1.25
Heteroplasmic point mutations of mitochondrial DNA affecting subunit I of cytochrome c oxidase in two patients with acquired idiopathic sideroblastic anemia. Blood (1997) 1.24
The 5q- syndrome. Hematology (2004) 1.23
The stem cell mobilizing capacity of patients with acute myeloid leukemia in complete remission correlates with relapse risk: results of the EORTC-GIMEMA AML-10 trial. Leukemia (2003) 1.21
Syringe exchange in Germany. Subst Use Misuse (1998) 1.20
Whole-body positron emission tomography using 18F-fluorodeoxyglucose compared to standard procedures for staging patients with Hodgkin's disease. Haematologica (2001) 1.20
Positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) for the staging of low-grade non-Hodgkin's lymphoma (NHL). Ann Oncol (2001) 1.18
Automatic and controlled processing revisited. Psychol Rev (1984) 1.17
Changes in spatial patterns of rabbit olfactory EEG with conditioning to odors. Psychophysiology (1982) 1.16
Histomorphology and bone morphometry of the bone marrow edema syndrome of the hip. Clin Orthop Relat Res (1997) 1.15
Validation of the WHO proposals for a new classification of primary myelodysplastic syndromes: a retrospective analysis of 1600 patients. Leuk Res (2000) 1.14
Anti-endothelial cell antibodies in Takayasu arteritis. Circulation (1996) 1.13
Principles and procedures in female breast reconstruction in the young child's burn injury. Aesthetic Plast Surg (1988) 1.13
Quantitative assessment of erythropoiesis and functional classification of anemia based on measurements of serum transferrin receptor and erythropoietin. Blood (1993) 1.11
S-HAM induction chemotherapy with or without GM-CSF in patients with high-risk myelodysplastic syndromes. Ann Hematol (1997) 1.09
Angiotensin II (AT(1)) receptor blockade reduces vascular tissue factor in angiotensin II-induced cardiac vasculopathy. Am J Pathol (2000) 1.08
Clinical activity and benefit of irinotecan (CPT-11) in patients with colorectal cancer truly resistant to 5-fluorouracil (5-FU). Eur J Cancer (1999) 1.07
Reductive mobilisation of ferritin iron. Eur J Biochem (1985) 1.07
Bone marrow transplantation from HLA-identical siblings as first-line treatment in patients with myelodysplastic syndromes: early transplantation is associated with improved outcome. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant (1998) 1.07
High dose ara-C in the treatment of newly diagnosed acute promyelocytic leukemia: long-term results of the German AMLCG. Leukemia (2009) 1.07
[Lichen amyloidosus as example of pericollagenous, primary, skin limited and principally localized amyloidosis]. Arch Klin Exp Dermatol (1966) 1.07
Early detection of relapse by whole-body positron emission tomography in the follow-up of patients with Hodgkin's disease. Ann Oncol (2003) 1.07
Effect of bosentan on NF-kappaB, inflammation, and tissue factor in angiotensin II-induced end-organ damage. Hypertension (2000) 1.07
Prolonged cold preservation augments vascular injury independent of renal transplant immunogenicity and function. Kidney Int (2001) 1.06
Influence of infusion time on the acute toxicity of amphotericin B: results of a randomized double-blind study. Recent Results Cancer Res (1991) 1.05
STEP--a System for Teaching Experimental Psychology using E-Prime. Behav Res Methods Instrum Comput (2001) 1.05
The protean face of renal sarcoidosis. J Am Soc Nephrol (2001) 1.05
Composition, synthesis, and assembly of the embryonic chick retinal basal lamina. Dev Biol (2000) 1.04
Prognosis of patients with del(5q) MDS and complex karyotype and the possible role of lenalidomide in this patient subgroup. Ann Hematol (2005) 1.04
Developmental regulation of murine mammary progesterone receptor gene expression. Endocrinology (1990) 1.04
Cerivastatin prevents angiotensin II-induced renal injury independent of blood pressure- and cholesterol-lowering effects. Kidney Int (2000) 1.03
Whole-body 18F-FDG PET for the evaluation of patients with Hodgkin's disease and non-Hodgkin's lymphoma. Nucl Med Commun (1999) 1.03
Congenital asplenia detected in a 60 year old patient with septicemia. Eur J Med Res (1999) 1.01
Antiendothelial cell antibodies in thromboangiitis obliterans. Am J Med Sci (1998) 1.01
Treatment of relapsed idiopathic thrombocytopenic purpura with the anti-CD20 monoclonal antibody rituximab: a pilot study. Eur J Haematol (2002) 1.00
Optimal detection, classification, and superposition resolution in neural waveform recordings. IEEE Trans Biomed Eng (1993) 0.99
Treatment of bone-marrow oedema of the talus with the prostacyclin analogue iloprost. An MRI-controlled investigation of a new method. J Bone Joint Surg Br (2001) 0.98
Acute basophilic leukemia. Eur J Haematol (2001) 0.97
Core decompression in early stages of femoral head osteonecrosis--an MRI-controlled study. Int Orthop (2002) 0.97
Epidemiological survey of foot problems in the continental United States: 1978-1979. Foot Ankle (1980) 0.97
[On the problem of arterial vascular involvement in Behçet's disease (Touraine's aphthosis)]. Z Haut Geschlechtskr (1965) 0.97
[Surgical therapy of scrotal edema in elephantiasis congenita hereditaria (Meige type)]. Urologe A (2002) 0.97
Inhibition of pressure natriuresis in mice lacking the AT2 receptor. Kidney Int (2000) 0.96
The influence of urea on protein synthesis of stimulated lymphocytes. Klin Wochenschr (1972) 0.96
Fetomaternal hemorrhage (FMH), an update: review of literature and an illustrative case. Arch Gynecol Obstet (2015) 0.96
Usefullness of some pressure velocity parameters for evaluation of left ventricular contractility. Verh Dtsch Ges Kreislaufforsch (1973) 0.95
Effects of the bradycardic agent UL-FS 49 on exercise-induced regional contractile dysfunction in dogs. Int J Cardiol (1987) 0.95
Evaluation of the efficacy and tolerability of acarbose in patients with diabetes mellitus : a postmarketing surveillance study. Clin Drug Investig (2005) 0.95
[On the measurement of edema of the lower leg with help of the ultrasound impulse echo method]. Angiologica (1966) 0.95
Pediatric craniofacial surgery: comparison of milling and stereolithography for 3D model manufacturing. Pediatr Radiol (1992) 0.94